1-16053748-A-G
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000085.5(CLCNKB):āc.1732A>Gā(p.Lys578Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.67 in 1,610,920 control chromosomes in the GnomAD database, including 363,773 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Consequence
NM_000085.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CLCNKB | NM_000085.5 | c.1732A>G | p.Lys578Glu | missense_variant | 16/20 | ENST00000375679.9 | NP_000076.2 | |
CLCNKB | NM_001165945.2 | c.1225A>G | p.Lys409Glu | missense_variant | 9/13 | NP_001159417.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CLCNKB | ENST00000375679.9 | c.1732A>G | p.Lys578Glu | missense_variant | 16/20 | 1 | NM_000085.5 | ENSP00000364831.5 |
Frequencies
GnomAD3 genomes AF: 0.695 AC: 105369AN: 151652Hom.: 37116 Cov.: 32
GnomAD3 exomes AF: 0.653 AC: 163268AN: 250048Hom.: 54196 AF XY: 0.650 AC XY: 87976AN XY: 135366
GnomAD4 exome AF: 0.667 AC: 973531AN: 1459150Hom.: 326636 Cov.: 72 AF XY: 0.664 AC XY: 482151AN XY: 725916
GnomAD4 genome AF: 0.695 AC: 105426AN: 151770Hom.: 37137 Cov.: 32 AF XY: 0.693 AC XY: 51385AN XY: 74168
ClinVar
Submissions by phenotype
not provided Benign:4
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Jul 26, 2017 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 10, 2018 | This variant is associated with the following publications: (PMID: 26814133, 29105529) - |
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 21, 2016 | p.Lys578Glu in exon 16 of CLCNKB: This variant is not expected to have clinical significance because it has been identified in 79.60% (8227/10336) of African ch romosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute. org; dbSNP rs2275166). - |
Benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Dec 17, 2021 | - - |
Bartter disease type 3 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 22, 2021 | - - |
Bartter disease type 4B Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 22, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at